Huvitz Co. Ltd (065510) - Total Assets

Latest as of September 2025: ₩235.07 Billion KRW ≈ $159.30 Million USD

Based on the latest financial reports, Huvitz Co. Ltd (065510) holds total assets worth ₩235.07 Billion KRW (≈ $159.30 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Huvitz Co. Ltd (065510) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Huvitz Co. Ltd - Total Assets Trend (2011–2024)

This chart illustrates how Huvitz Co. Ltd's total assets have evolved over time, based on quarterly financial data. See Huvitz Co. Ltd (065510) net assets for net asset value and shareholders' equity analysis.

Huvitz Co. Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Huvitz Co. Ltd's total assets of ₩235.07 Billion consist of 41.1% current assets and 58.9% non-current assets.

Asset Category Amount (KRW) % of Total Assets
Cash & Equivalents ₩0.00 3.6%
Accounts Receivable ₩33.99 Billion 15.3%
Inventory ₩43.09 Billion 19.4%
Property, Plant & Equipment ₩94.85 Billion 42.7%
Intangible Assets ₩12.00 Billion 5.4%
Goodwill ₩0.00 0.0%

Asset Composition Trend (2011–2024)

This chart illustrates how Huvitz Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Huvitz Co. Ltd (065510) total market value.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Huvitz Co. Ltd's current assets represent 41.1% of total assets in 2024, an increase from 0.0% in 2011.
  • Cash Position: Cash and equivalents constituted 3.6% of total assets in 2024, down from 12.9% in 2011.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 1.0% in 2011.
  • Asset Diversification: The largest asset category is property, plant & equipment at 42.7% of total assets.

Huvitz Co. Ltd Competitors by Total Assets

Key competitors of Huvitz Co. Ltd based on total assets are shown below.

Company Country Total Assets
Bio-Rad Laboratories Inc
NYSE:BIO
USA $9.79 Billion
Double Medical Technology Inc
SHE:002901
China CN¥5.03 Billion
Tellgen Corp
SHE:300642
China CN¥2.01 Billion
Affluent Medical SAS
PA:AFME
France €59.84 Million
Cochlear Ltd
AU:COH
Australia AU$2.83 Billion
4DMEDICAL Ltd
AU:4DX
Australia AU$139.55 Million
Anteris Technologies Global Corp
AU:AVR
Australia AU$19.07 Million
Imricor Medical Systems Inc
AU:IMR
Australia AU$45.79 Million

Huvitz Co. Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.12 1.13 1.22
Quick Ratio 0.58 0.63 0.77
Cash Ratio 0.00 0.00 0.00
Working Capital ₩10.91 Billion ₩11.16 Billion ₩11.33 Billion

Huvitz Co. Ltd - Advanced Valuation Insights

This section examines the relationship between Huvitz Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.77
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) 10.4%
Total Assets ₩222.13 Billion
Market Capitalization $51.60 Million USD

Valuation Analysis

Below Book Valuation: The market values Huvitz Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Huvitz Co. Ltd's assets grew by 10.4% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Huvitz Co. Ltd (2011–2024)

The table below shows the annual total assets of Huvitz Co. Ltd from 2011 to 2024.

Year Total Assets Change
2024-12-31 ₩222.13 Billion
≈ $150.54 Million
+10.43%
2023-12-31 ₩201.14 Billion
≈ $136.31 Million
+13.51%
2022-12-31 ₩177.21 Billion
≈ $120.09 Million
+15.53%
2021-12-31 ₩153.40 Billion
≈ $103.95 Million
-1.34%
2020-12-31 ₩155.47 Billion
≈ $105.36 Million
+2.35%
2019-12-31 ₩151.90 Billion
≈ $102.94 Million
+7.22%
2018-12-31 ₩141.66 Billion
≈ $96.00 Million
+0.55%
2017-12-31 ₩140.88 Billion
≈ $95.47 Million
+0.98%
2016-12-31 ₩139.52 Billion
≈ $94.55 Million
+21.80%
2015-12-31 ₩114.55 Billion
≈ $77.63 Million
+7.21%
2014-12-31 ₩106.84 Billion
≈ $72.41 Million
+5.12%
2013-12-31 ₩101.64 Billion
≈ $68.88 Million
+21.18%
2012-12-31 ₩83.87 Billion
≈ $56.84 Million
+23.13%
2011-12-31 ₩68.11 Billion
≈ $46.16 Million
--

About Huvitz Co. Ltd

KQ:065510 Korea Medical Devices
Market Cap
$51.60 Million
₩76.15 Billion KRW
Market Cap Rank
#21699 Global
#1273 in Korea
Share Price
₩7000.00
Change (1 day)
+4.01%
52-Week Range
₩6410.00 - ₩9830.00
All Time High
₩24879.57
About

Huvitz Co., Ltd. develops and sells optometric medical equipment worldwide. The company offers ophthalmic and optical equipment comprising refractive equipment, such as auto ref-keratometers, auto lensmeters, digital refractors, chart projectors, and unit tables; and diagnostic equipment comprising slit lamps, non-contact tonometers, and applanation tonometers, as well as ophthalmologic diagnosti… Read more